It has been demonstrated that cinnamaldehyde and cinnamon treatment leads to downregulation of the NF-κB pathway and reduces the levels of proinflammatory cytokines in diseases such as T2D and atherosclerosis in ApoE−/− mice [124, 125]. Here, NFKB1 is linked to type 2 diabetes mellitus.